ALBANY MOLECULAR RESH INC's ticker is AMRI and the CUSIP is 012423109. A total of 117 filers reported holding ALBANY MOLECULAR RESH INC in Q1 2014. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,866,000 | +29.4% | 132,055 | -16.3% | 0.01% | +42.9% |
| Q1 2017 | $2,215,000 | +36.8% | 157,860 | +61.0% | 0.01% | +16.7% |
| Q3 2016 | $1,619,000 | +313.0% | 98,075 | +236.0% | 0.01% | +200.0% |
| Q2 2016 | $392,000 | -83.5% | 29,191 | -81.2% | 0.00% | -81.8% |
| Q1 2016 | $2,375,000 | -32.4% | 155,306 | -12.3% | 0.01% | -35.3% |
| Q4 2015 | $3,514,000 | +490.6% | 177,038 | +418.1% | 0.02% | +466.7% |
| Q3 2015 | $595,000 | -74.4% | 34,171 | -70.2% | 0.00% | -72.7% |
| Q2 2015 | $2,322,000 | +75.0% | 114,816 | +91.0% | 0.01% | +83.3% |
| Q3 2014 | $1,327,000 | -52.1% | 60,116 | -56.4% | 0.01% | -50.0% |
| Q2 2014 | $2,773,000 | +12.7% | 137,809 | +4.1% | 0.01% | -7.7% |
| Q1 2014 | $2,460,000 | +814.5% | 132,342 | +395.6% | 0.01% | +1200.0% |
| Q4 2013 | $269,000 | +126.1% | 26,702 | +166.9% | 0.00% | 0.0% |
| Q2 2013 | $119,000 | – | 10,003 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 567,400 | $11,473,000 | 12.05% |
| Permian Investment Partners, LP | 1,875,650 | $37,926,000 | 7.67% |
| OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 1,490,174 | $30,131,000 | 2.57% |
| AMERICAN CAPITAL MANAGEMENT INC | 993,280 | $20,084,000 | 1.91% |
| Netols Asset Management, Inc. | 387,471 | $7,835,000 | 1.54% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,158,759 | $23,430,000 | 1.35% |
| Evercore Wealth Management, LLC | 1,233,880 | $24,948,000 | 1.13% |
| Visium Asset Management, LP | 3,200,000 | $64,704,000 | 0.92% |
| Granite Investment Partners, LLC | 303,787 | $6,143,000 | 0.57% |
| FRANKLIN STREET ADVISORS INC /NC | 144,125 | $2,914,000 | 0.52% |